Dr. Nagourney's Blog

Email-box.png

Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Future (Cancer) Shock - HSP90 Inhibitors
By Robert A. Nagourney, MD
Two related clinical trials were reported in the last several months describing the use of heat shock protein 90 (HSP90) inhibitors in lung cancer. Both trials fell short of their pre-specified endpoints casting a pall upon these drugs....
Every Cancer Patient Outcome is Important - Stage 4 Stomach Cancer
By Robert A. Nagourney, MD
Clinical oncologists can be divided into different camps. There are those who see patient outcomes as a means-to-an-end. Each...
A New Target in Breast Cancer Therapy
By Robert A. Nagourney, MD
In many ways the era of targeted therapy began with the recognition that breast cancers expressed estrogen receptors, the...
Targeted Therapies — The Next Chapter
By Robert A. Nagourney, MD
Within this blog, we have intermittently reviewed the concept of targeted therapies. To reiterate, these are classes of drugs...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.